pregnanolone has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Akins, NS; Le, HV; Li, J; Mahdi, F; Moss, E; Paris, JJ; Qrareya, AN; Salahuddin, MF | 1 |
Mahdi, F; Paris, JJ; Salahuddin, MF; Sulochana, SP | 1 |
1 review(s) available for pregnanolone and HIV Coinfection
Article | Year |
---|---|
Allopregnanolone and neuroHIV: Potential benefits of neuroendocrine modulation in the era of antiretroviral therapy.
Topics: Central Nervous System; HIV Infections; HIV-1; Humans; Neurosecretory Systems; Pregnanolone | 2022 |
1 other study(ies) available for pregnanolone and HIV Coinfection
Article | Year |
---|---|
HIV-1 Tat Protein Promotes Neuroendocrine Dysfunction Concurrent with the Potentiation of Oxycodone's Psychomotor Effects in Female Mice.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Estrous Cycle; Female; HIV Infections; HIV-1; Humans; Hypothalamo-Hypophyseal System; Mice; Motor Activity; Neurosecretory Systems; Oxycodone; Pituitary-Adrenal System; Pregnanolone; Psychomotor Performance; Steroids; tat Gene Products, Human Immunodeficiency Virus | 2021 |